Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Alfred Gitu

Primary Care · LMHS

View

Dr. Bayo Curry-winchell

Primary Care · Clinicians Who Care

View

Dr. Kirsten Meisinger

Primary Care · CHA

View

Dr. Kameron Matthews

Primary Care · IMPaCT Care

View

Dr. Sarah Ro

Obesity Medicine · UNC Health Care

View

Dr. Christina Nguyen

Obesity Medicine · Knownwell

View

Dr. E. Robert Schwartz

Behavioral Medicine · University of Miami

View

Dr. Jennah Siwak

Obesity Medicine · Carle Foundation Hospital

View

Dr. Tema Fodje

General Family Medicine · U.S. Navy

View

Dr. Reid Blackwelder

General Family Medicine · ETSU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RRDr. Reshma Ramachandran

    Dr. Reshma Ramachandran

    Family Medicine · Primary Care
    Yale University
    reshma

    Research

    Venture Capital Investments by Academic Medical Centers in Health Care Companies

    2026

    Via JAMA Internal Medicine

    Research

    Postmarket Safety Actions for Novel Oncology Drugs Granted FDA's Accelerated Approval

    2026

    Via JAMA Network Open

    Research

    Postmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments Act

    2026

    Via JAMA Internal Medicine

    Research

    Premarket and Postmarket Real-World Evidence Studies Supporting US Food and Drug Administration Regulatory Decision-Making, 2016–2024

    2026

    Via Clinical Trials

    Research

    Politics, Science, and the Future of FDA Drug Regulation: FDA's Review of Mifepristone REMS as a Litmus Test

    2026

    Via JAMA

    Research

    FDA Approval of Benzgalantamine Exposes Flaws in the 505(b)(2) Pathway for Innovations on Existing Drugs

    2026

    Via BMJ Evidence-Based Medicine

    Research

    Pharmaceutical Manufacturer Kickback Resolutions and Associated Financial Penalties, 2000–2025

    2026

    Via JAMA Network Open

    Research

    Use of Low-Value Cancer Care in Practices Acquired by Private Equity Firms

    2026

    Via Journal of the National Cancer Institute

    Research

    Never Waste a Crisis: The Past, Present, and Future of FDA Reform

    2026

    Via Journal of Health Politics, Policy and Law

    Research

    Advertising Payments to News Websites That Publish Health Misinformation

    2026

    Via JAMA Network Open

    Research

    US Food and Drug Administration Sentinel Initiative and Postmarket Drug Safety Surveillance: A Review

    2026

    Via JAMA Health Forum

    Research

    Evidence Supporting European Medicines Agency Drug Approvals (2020–2023): A Cross-Sectional Study of Trial Design and Outcomes

    2026

    Via Clinical Trials

    Research

    Surrogate Markers Used as Efficacy Endpoints in NIH-Sponsored Clinical Trials

    2026

    Via Clinical Trials

    Research

    Industry Promotion of Oncology Drugs with Accelerated Approval That Failed Confirmatory Trials

    2026

    Via Journal of the National Cancer Institute

    Research

    Polypharmacy Among US Older Adults with Limited English Proficiency: 2013-2018

    2026

    Via Journal of General Internal Medicine